Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
GLP-1 receptor agonist therapy was associated in these cases with reduction or resolution of hypoglycaemic episodes and improvement in dumping-related symptoms
But of the 13 consensus ratings of the companies in its portfolio, 11 assign the ETF a Buy or Moderate Buy rating, while just two assign it a Hold, and none rate it a Sell
Hiona, A
Demand for GLP-1 improves the capacity utilisation of fill-finish capabilities offered by CDMOs While GLP-1 manufacturers are investing significantly in the development of the drug, few have the capacity to complete filling and packaging in-house
US$ 27.29
US$ 25.04
US$ 25.57
US$ 23.28
US$ 25.73
US$ 22.14
